These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effects of endothelin antagonist BQ-610 on cerebral vascular wall following experimental subarachnoid hemorrhage and cerebral vasospasm. Cirak B; Kiymaz N; Ari HH; Ugras S Clin Auton Res; 2004 Jun; 14(3):197-201. PubMed ID: 15241650 [TBL] [Abstract][Full Text] [Related]
3. Endothelin receptor antagonists and cerebral vasospasm. Zimmermann M; Seifert V Clin Auton Res; 2004 Jun; 14(3):143-5. PubMed ID: 15241641 [No Abstract] [Full Text] [Related]
4. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series. Barth M; Capelle HH; Münch E; Thomé C; Fiedler F; Schmiedek P; Vajkoczy P Acta Neurochir (Wien); 2007; 149(9):911-8; discussion 918. PubMed ID: 17700991 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the endothelin-B receptor expression and vasomotor function during experimental cerebral vasospasm. Vatter H; Konczalla J; Weidauer S; Preibisch C; Raabe A; Zimmermann M; Seifert V Neurosurgery; 2007 Jun; 60(6):1100-8; discussion 1108-9. PubMed ID: 17538385 [TBL] [Abstract][Full Text] [Related]
11. Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy? Zemke D; Farooq MU; Mohammed Yahia A; Majid A Vasc Med; 2007 Aug; 12(3):243-9. PubMed ID: 17848485 [TBL] [Abstract][Full Text] [Related]
12. 17beta-estradiol inhibits endothelin-1 production and attenuates cerebral vasospasm after experimental subarachnoid hemorrhage. Lin CL; Dumont AS; Wu SC; Wang CJ; Howng SL; Huang YF; Wong WY; Kassell NF; Jeng AY; Kwan AL Exp Biol Med (Maywood); 2006 Jun; 231(6):1054-7. PubMed ID: 16741048 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of disease: roles of nitric oxide and endothelin-1 in delayed cerebral vasospasm produced by aneurysmal subarachnoid hemorrhage. Suhardja A Nat Clin Pract Cardiovasc Med; 2004 Dec; 1(2):110-6; quiz 2 p following 116. PubMed ID: 16265315 [TBL] [Abstract][Full Text] [Related]
15. Endothelins and the cerebral circulation. Salom JB; Torregrosa G; Alborch E Cerebrovasc Brain Metab Rev; 1995; 7(2):131-52. PubMed ID: 7669492 [TBL] [Abstract][Full Text] [Related]
16. Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage. Lu H; Shi JX; Chen HL; Hang CH; Wang HD; Yin HX Brain Res; 2009 Mar; 1262():73-80. PubMed ID: 19401162 [TBL] [Abstract][Full Text] [Related]
18. Profile of past and current clinical trials involving endothelin receptor antagonists: the novel "-sentan" class of drug. Battistini B; Berthiaume N; Kelland NF; Webb DJ; Kohan DE Exp Biol Med (Maywood); 2006 Jun; 231(6):653-95. PubMed ID: 16740981 [TBL] [Abstract][Full Text] [Related]
19. ERK1/2 inhibition attenuates cerebral blood flow reduction and abolishes ET(B) and 5-HT(1B) receptor upregulation after subarachnoid hemorrhage in rat. Beg SA; Hansen-Schwartz JA; Vikman PJ; Xu CB; Edvinsson LI J Cereb Blood Flow Metab; 2006 Jun; 26(6):846-56. PubMed ID: 16251886 [TBL] [Abstract][Full Text] [Related]
20. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]